drugset / Trial / NCT02044367
Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
To investigate the relative bioavailability of dabigatran etexilate as pellets on food and of dabigatran etexilate as granules resolved in reconstitution solution, each with dabigatran etexilate as capsule following oral administration. To evaluate acceptability and palatability of Pellets sprinkled on food and Oral Liquid Formulation
Timeline
- Start
- 2014-01
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabigatran etexilate | Unknown | 150 mg | Oral |
Indications
No indication recorded.